Network origin in Pavan Cheruvu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 27 | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pavan Cheruvu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member President | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Founder Director/Board Member Chief Operating Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman President | |
| MYOVANT SCIENCES LTD. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Chairman Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| NUVATION BIO INC. | Biotechnology | Founder Director/Board Member Director/Board Member Corporate Officer/Principal | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Founder Founder Founder | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| UNC School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Santa Clara University | College/University | Undergraduate Degree Undergraduate Degree | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The private company is based in San Francisco, CA. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| NOVOCURE LIMITED | Medical Specialties | Director/Board Member Director/Board Member | |
| Ernest Mario School of Pharmacy | College/University | Doctorate Degree | |
| University of the Witwatersrand | College/University | Graduate Degree | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 39 |
| United Kingdom | 7 |
| Switzerland | 4 |
| Netherlands | 2 |
| Bermuda | 2 |
Sectoral
| Health Technology | 36 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 3 |
Operational
| Director/Board Member | 229 |
| Independent Dir/Board Member | 74 |
| Corporate Officer/Principal | 66 |
| Chief Executive Officer | 40 |
| Director of Finance/CFO | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Myrtle Potter | 41 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Tony Vernon | 34 |
| Kathryn Falberg | 30 |
| Clarence Machado | 29 |
| David Hung | 24 |
| Gregory Mark Weinhoff | 21 |
| Roger Jeffs | 18 |
| Eric Floyd | 18 |
| Kristiina Vuori | 16 |
| Mark Altmeyer | 16 |
| Paul Korner | 14 |
| Vivek Ramaswamy | 14 |
| Thomas S. Templeman | 14 |
- Stock Market
- Insiders
- Pavan Cheruvu
- Company connections